Mesa Laboratories, Inc. reported its fourth-quarter and full fiscal year 2025 financial results, showing a 5.5% increase in total revenues for the fourth quarter compared to the same period in the previous year. The company achieved $62.1 million in revenues for the quarter and $241 million for the full fiscal year, marking an 11.5% increase year-over-year. Operating income for the fourth quarter surged by 100.5% to reach $1.5 million. However, the company reported a net loss of $7.1 million for the fourth quarter. For the full fiscal year, Mesa Laboratories delivered a 5.0% growth in core organic revenues, with improvements noted in three out of the four operational divisions and bookings growth across all divisions. The company also generated $46.8 million in cash flows from operations and $42.6 million in free cash flow, primarily used to reduce debt, lowering the Net Leverage Ratio to 3.01. While the company's adjusted operating income, excluding unusual items, decreased by 18% for the fourth quarter, it stood at 19.7% as a percentage of revenues, impacted by increased performance-based compensation expenses. Mesa Laboratories continues to focus on driving profitable market share growth amidst ongoing global economic challenges.